Milestone: Creating Innovative Solutions Milestone Home
 
image thru microscope
Symposia Contact Home

CPSA Digest 2003

From Proteomics to the Pill:
New Initiatives in Proteomics, Drug Discovery, and Development

September 22-24, 2003

CPSA Digest 2003

Day 1: Proceedings | Plenary
Day 2: Proceedings
Day 3: Proceedings

CPSA 2003 Sponsors

CPSA Digest Archive
CPSA Digest 2000
CPSA Digest 2001
CPSA Digest 2002
CPSA Digest 2003 >>
CPSA Digest 2004


Proceedings

Day 2 - Tuesday, September 23, 2003



Lead Optimization

Discussion Leader: Jonathan Burbaum, ActivX Biosciences

Using Comprehensive Metabolomics to Determine and Classify the Mode(s) of Action of New Chemical Entities and their Relative Toxicity Risks

Dayan Goodenowe, Phenomenome Discoveries

Automated Approaches to the Detection and Characterization of Pharmaceutical Metabolites by the Application of MS/MS Software Algorithms

Jonathan Josephs, Bristol-Myers Squibb

New Methods for Rapid Analysis of Radiocarbon-labeled Drugs by Accelerator Mass Spectrometry

Paul L. Skipper, Massachusetts Institute of Technology

Roundtable Discussion



Reactive Xenobiotic Intermediates

Discussion Leader: Chung-Ping Yu, GlaxoSmithKline

A High Throughput LC-MS-MS Method for Screening Glutathione Conjugations Using Exact Mass Neutral Loss

Li Liang, GlaxoSmithKline

Reactive Intermediates in Drug Metabolism: Tools and Toxicology

Michael L. Schrag, Merck Research Laboratories

Mechanistic Investigation Into the Formation of Reactive Metabolites in Drug Discovery and Development

Jack Wang and Jim Wang, Wyeth Research

Roundtable Discussion



Compound Library Analysis and Profiling

Discussion Leader: Robyn A. Rourick, Kalypsys

Strategies for Predictive Library Rehearsal, Design and QC that Deliver High Quality Combinatorial Libraries

James Connelly, Aventis

Repository Compound Stability and Quality Studies in Support of Lead Discovery

Xueheng Cheng, Abbott Laboratories

Design and Implementation of Technologies to Purify 10,000 Samples Per Month

John Isbell, Genomics Institute of the Novartis Research Foundation

High Throughput Liquid Chromatography Systems for Compound Library Screening

Steve O'Connor, Nanostream

Roundtable Discussion



Conversion of Data to Information: Dissemination of Information to Drive Therapeutic Area Projects

Discussion Leader: Eric Milgram, Pfizer Global R&D

Visual Basic for Applications (VBA): A Powerful Tool for Automated Data Processing

Eric Milgram, Pfizer Global R&D

Data Transformation and Processing in CYP-Inhibition HTS Assays

Mingdan Wu, Aventis

Enabling Collaboration Across Multiple Disciplines to Accelerate Drug Discovery

Francois Mandeville, Agilent Technologies

Bringing Biology to Proteomics: Integration with Functional Genomics

Todd Pihl, Celera Genomics

Roundtable Discussion



Vendor/Exhibitor Session

Drug Discovery Technologies & Applications

Discussion Leaders: John D. Laycock, Amgen

Automated Method Development for Solid Phase Extraction in an Online SPE/LC/MS System

Steven Eendhuizen and Alex Berhitu, Spark Holland Inc.

Plasma Protein Binding Determination By Equilibrium Dialysis Based On LC/MS/MS Peak Area Ratios In Support Of Drug Discovery

Zamas Lam, Quest Pharmaceutical Services

Overview of Isothermal Titration Calorimetry and Differential Scanning Calorimetry

Michael Lebrun, MicroCal, LLC

High Throughput Applications of Multiplexed Capillary Electrophoresis with Absorbance Detection in Drug Discovery and Development

Jeremy Kenseth, Andrea Bastin, and Dennis Tallman, CombiSep, Inc.

Sustained Carryover Elimination in LC/MS Drug Analysis

Megan Thurmond and Hank Hodgin, Alcott Chromatography

Parallel Liquid Chromatography for High Throughput ADMET Profiling

Chris Phillips, Nanostream

Increased Throughput and Separation in Nano-HPLC-MS Using a Dual-Gradient Nano-HPLC System and Monolithic Columns

Remco van Soest, LC Packings/Dionex, Sunnyvale, CA

High Throughput Microfluidic HPLC-UV System

Jeff Jensen, Eksigent Technologies

Drug Discovery Technologies & Applications

Luke Roenneburg, Gilson, Inc.

The Sensitivity Increase with IONICS EP 10+ System

Dragan Vuckovic, IONICS Mass Spectrometry Group

A Novel MS Based Metabonomic Approach to the Determination of Biomarkers of Drug Toxicity

Gary Harland, Waters Corporation

Accurate and MSn Mass Spectra in Combination with Smart Processing Tools for Metabolite Identification

Carsten Baessmann, Bruker Daltonik GmbH

A Practical Cryodetector Mass Spectrometer for High Sensitivity Detection and Energy Resolution at High Mass

Brian Musselman, SciMarket Strategies

The Finnigan TSQ Quantum Triple Quadrupole Mass Spectrometer Product Line: High Performance Quantitation at Unit and Enhanced Mass-Resolution with Accurate Mass Measurement Capabilities

Gary Paul, Thermo Electron Corporation

Application of MALDI-MS Imaging Software for Small Molecule Profiling in Tissue Samples

Julie Wingate, Applied Biosystems/MDS Sciex

A Quick Overview of Novatia's Metlab Software

Kathleen Anderson, Novatia

Using ChemAnalytics to Support the Drug Discovery Process

Kevin Turnbull, Advanced Chemistry Development, Inc.

Automated Capture, Cataloging and Re-use Platform for Data Management

John P. Helfrich, NuGenesis Technologies Corporation

A Flexible Asset Management Program for Drug Discovery Instrument Acquisition

Paul Corcoran, McKinley Scientific


Poster Sessions

Chairs: Mingdan Wu, Aventis and Mingshe Zhu, Bristol-Myers Squibb
  1. Structure Identification
  2. Bioanalysis and ADME Screening
  3. Pharmaceutical Profiling
  4. Data Analysis
  5. New Applications, Methodologies & Technologies




overview | training | workshops | consulting | symposia | contact | home